Arrowpoint Investment Partners (Singapore) Pte. Ltd.

Position in LLY — ELI LILLY & Co

CIK 2032331 SINGAPORE, U0

Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,056,147

+$2,649,609 QoQ

Shares Held

2,548

+476.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

#2,111

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $7,535,126 across 3 Drug Manufacturers - General names. LLY ranks #1 (40.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,548	$3,056,147
2	ABBV	AbbVie Inc.	11,928	$3,001,561
3	BIIB	Biogen Inc.	6,838	$1,477,418

All Filings in LLY

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,056,147	2,548	+476.5%	Shares	Defined	2026-08-13
2026-03-31	$406,538	442	-95.2%	Shares	Defined	2026-05-14
2025-12-31	$9,879,534	9,193	—	Shares	Defined	2026-02-11
No filing history on record for this holder in this stock.